Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Tenney

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Antimicrobial Agents and Chemotherapy|January 7, 1998
Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymeraseD J Tenney, G Yamanaka, S M Voss, et al.
Journal of Virology|January 22, 2000
Isolation of herpes simplex virus procapsids from cells infected with a protease-deficient mutant virusW W Newcomb, B L Trus, N Cheng, et al.
Journal of Virology|May 1, 1996
Developmental analysis of the cytomegalovirus enhancer in transgenic animalsJ F Baskar, P P Smith, G S Ciment, et al.
Journal of Virology|January 1, 1993
Mutations in the C terminus of herpes simplex virus type 1 DNA polymerase can affect binding and stimulation by its accessory protein UL42 without affecting basal polymerase activityD J Tenney, P A Micheletti, J T Stevens, et al.
Journal of Virology|May 1, 1996
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic miceJ F Baskar, P P Smith, G Nilaver, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to LamivudineD J Tenney, S M Levine, R E Rose, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Antimicrobial Agents and Chemotherapy|January 7, 1998
Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymeraseD J Tenney, G Yamanaka, S M Voss, et al.
Journal of Virology|January 22, 2000
Isolation of herpes simplex virus procapsids from cells infected with a protease-deficient mutant virusW W Newcomb, B L Trus, N Cheng, et al.
Journal of Virology|May 1, 1996
Developmental analysis of the cytomegalovirus enhancer in transgenic animalsJ F Baskar, P P Smith, G S Ciment, et al.
Journal of Virology|January 1, 1993
Mutations in the C terminus of herpes simplex virus type 1 DNA polymerase can affect binding and stimulation by its accessory protein UL42 without affecting basal polymerase activityD J Tenney, P A Micheletti, J T Stevens, et al.
Journal of Virology|May 1, 1996
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic miceJ F Baskar, P P Smith, G Nilaver, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to LamivudineD J Tenney, S M Levine, R E Rose, et al.
Pageof 3